Liberski S, Kaluzny BJ, Kocięcki J. Methanol-induced optic neuropathy: A still-present problem. Archives of Toxicology. 2022:1-21.

Pressman P, Clemens R, Sahu S, Hayes AW. A review of methanol poisoning: a crisis beyond ocular toxicology. Cutaneous and ocular toxicology. 2020;39(3):173-9.

Akhgari M, Panahianpour MH, Bazmi E, Etemadi-Aleagha A, Mahdavi A, Nazari SH. Fatal methanol poisoning: features of liver histopathology. Toxicology and industrial health. 2013;29(2):136-41.

Fu J, Jiao J, Weng K, Yu D, Li R. Zebrafish methanol exposure causes patterning defects and suppressive cell proliferation in retina. American Journal of Translational Research. 2017;9(6):2975.

Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta ophthalmologica. 2015;93(5):402-10.

Klein KA, Warren AK, Baumal CR, Hedges TR. Optical coherence tomography findings in methanol toxicity. International Journal of Retina and Vitreous. 2017;3(1):1-6.

BENNETT Jr IL, CARY FH, MITCHELL Jr GL, COOPER MN. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine. 1953;32(4):431-63.

Tanrivermis Sayit A, Aslan K, Elmali M, Gungor I. Methanol-induced toxic optic neuropathy with diffusion weighted MRI findings. Cutaneous and Ocular Toxicology. 2016;35(4):337-40.

Sharma R, Marasini S, Sharma AK, Shrestha JK, Nepal BP. Methanol poisoning: ocular and neurological manifestations. Optometry and vision science. 2012;89(2):178-82.

Pakravan M, Esfandiari H, Sanjari N, Ghahari E. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. The American Journal of Drug and Alcohol Abuse. 2016;42(6):633-9.

Feizi S, Alemzadeh-Ansari M, Karimian F, Esfandiari H. Use of erythropoietin in ophthalmology: A review. Survey of Ophthalmology. 2022;67(2):427-39.

Patel S, Rowe MJ, Winters SA, Ohls RK. Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatric research. 2008;63(4):394-7.

Rex TS, Allocca M, Domenici L, Surace EM, Maguire AM, Lyubarsky A, et al. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Molecular Therapy. 2004;10(5):855-61.

Chung H, Lee H, Lamoke F, Hrushesky WJ, Wood PA, Jahng WJ. Neuroprotective role of erythropoietin by antiapoptosis in the retina. Journal of Neuroscience Research. 2009;87(10):2365-74.

Gong Y, Qiu Y, Song Z, Gu Q, Wu X, Sun X. Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats. Current Eye Research. 2011;36(8):739-46.

Pakravan M, Sanjari N. Erythropoietin treatment for methanol optic neuropathy. Journal of Neuro-Ophthalmology. 2012;32(4):325-8.

Pakdel F, Sanjari MS, Naderi A, Pirmarzdashti N, Haghighi A, Kashkouli MB. Erythropoietin in treatment of methanol optic neuropathy. Journal of Neuro-Ophthalmology. 2018;38(2):167-71.

Zamani N, Hassanian-Moghaddam H, Shojaei M, Rahimian S. Evaluation of the effect of erythropoietin+ corticosteroid versus corticosteroid alone in methanol-induced optic nerve neuropathy. Cutaneous and Ocular Toxicology. 2018;37(2):186-90.

Nekoueifard S, Majidi M. Subcutaneous Erythropoietin Reverses Optic Neuropathy Induced by Methanol Poisoning: Three Case Reports. Iranian Journal of Toxicology. 2020;14(3):187-92.

Vafapour F, Jahangiri-Mehr S, Hassanzadeh S. Delayed reversal of methanol-induced blindness in an adult by a combination of erythropoietin and a high dose of methylprednisolone: a case report. Journal of Medical Case Reports. 2023;17(1):181.

Tabatabaei SA, Amini M, Haydar AA, Soleimani M, Cheraqpour K, Shahriari M, et al. Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy. World Journal of Clinical Cases. 2023;11(15):3502-10.

Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular psychiatry. 2007;12(2):206-20.

Borhani-Haghighi A, Ghodsi M, Razeghinejad MR, Mardani S, Mardani M, Nikseresht AR, et al. Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event. Neurosciences Journal. 2012;17(2):151-5.

Kashkouli MB, Pakdel F, Sanjari MS, Haghighi A, Nojomi M, Homaee MH, et al. Erythropoietin: a novel treatment for traumatic optic neuropathy—a pilot study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2011;249:731-6.

Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, et al. A randomized, double‐blind, phase 2 study of erythropoietin in optic neuritis. Annals of neurology. 2012;72(2):199-210.

İşcan Y, Coşkun Ç, Öner V, Türkçü FM, Taş M, Alakuş MF. Bilateral total optic atrophy due to transdermal methanol intoxication. Middle East African Journal of Ophthalmology. 2013;20(1):92.

Beccari M. Erythropoietin-induced epilepsy in hemodialysis patients? Nephron. 1998;78(3):354-.

Samtleben W, Baldamus C, Bommer J, Grützmacher P, Nonnast-Daniel B, Scigalla P, et al. Indications and contraindications for recombinant human erythropoietin treatment. Erythropoietin: from molecular structure to clinical application. 76: Karger Publishers; 1990. p. 193-200.

Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. Journal of internal medicine. 1991;229(2):125-30.